Business Wire

2020 World Young Scientist Summit Fosters a Global Youth Community for Science and Innovation

20.10.2020 13:38:00 EEST | Business Wire | Press release

Share

The 2020 World Young Scientist Summit (WYSS) was held on October 18-19, 2020, in Wenzhou, Zhejiang Province, bringing together representatives from 125 countries/regions and international organizations. Participants included world-class scientists, Nobel laureates, and 113 academics from China and overseas, around 70% of whom were aged under 45.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201020005621/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Young scientists recite the Wenzhou Declaration of the World Young Scientist Summit in multiple languages on October 18, 2020. (Photo: Xinhua/Cuili)

The WYSS is an annual event for leading young global talent, jointly sponsored by the China Association for Science and Technology (CAST) and the People's Government of Zhejiang Province.

The 2020 Summit boasted an extensive program divided into four sections: Moment of Science, Dialogue with the Future, Engagement & Sharing, and Realizing Dreams, and included around 30 sessions and activities, such as the Global Young Scientist Scholar Roundtable and International Forum on Comprehensive Healthcare.

Due to the pandemic, the Summit was held both online and offline to allow participants across the globe to connect and converse with each other. Adopting the theme “Converging the World's Talents, Creating a Better Future,” it served as an international, youth-oriented, science-focused platform to develop a global vision, discuss international issues, share China’s perspectives, and also present Zhejiang to the world.

The worldwide spread of COVID-19 has brought dramatic changes to the global public health system and international order. As future world leaders, young scientists have a responsibility to share knowledge and ideas to build a community with a shared future for humankind and help create better lives for people around the globe. According to Wan Gang, Vice Chairman of the National Committee of the Chinese People's Political Consultative Conference and President of the Chinese Association for Science and Technology, China has officially joined the WHO-led program COVAX, to work with the international community to address global uncertainties caused by the pandemic.

During the Summit, the 16th China Youth Science and Technology Award Ceremony was also held to recognize 100 young scientists selected for their outstanding contributions to the nation's socio-economic development and science, technology, and innovation.

This year, the Summit added a new session, the Global Young Scientist Scholar Roundtable, co-hosted by several international organizations, including the Young Earth Scientists (YES) Network, the Global Young Academy, the World Academy of Sciences, and the UN Human Settlements Programme, where the participants from China and abroad jointly issued the “Wenzhou Declaration of the World Young Scientist Summit”.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Wei Wang
info@xinhuaeurope.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 05:00:00 EEST | Press release

Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and

Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 02:51:00 EEST | Press release

Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equity among HCPs, patients, regulators and other stakeholders. A global leader in women’s health, the company’s portfolio includes more than 70 products across Women’s Health and General Medicines, which includes biosimila

PMC Organometallix Announces Price Increase on All Products25.4.2026 00:02:00 EEST | Press release

Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli

Frankfurt Higher Regional Court upholds BESREMi ® arbitral award in favor of AOP Health24.4.2026 19:52:00 EEST | Press release

Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into

Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher24.4.2026 17:37:00 EEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the U.S. Food and Drug Administration (FDA) granted Compass NDA rolling review request and selected COMP360, Compass’ proprietary formulation of synthetic psilocybin, for the Commissioner's National Priority Voucher (CNPV) program for treatment-resistant depression (TRD). Companies selected for the voucher program will be entitled to benefits including enhanced communications and a shortened 1-2 month review time following filing of a New Drug Application (NDA), while maintaining FDA’s rigorous safety and efficacy standards. “We are honored and grateful to be selected for the CNPV which is a clear validation of both the urgent unmet need facing millions of people living with treatment resistant depression and the innovative science of COMP360,” said Kabir Nath, Chief Executive Officer of Compass Pathways. “As the most advan

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye